Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
Sun Pharma today announced the successful completion of its acquisition of Concert Pharmaceuticals, a late-stage clinical […]
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and […]
Laura Murina-Indriksone, Informa Markets, on the Importance of Pharmapack
In this video Laura Murina-Indriksone, Brand Manager for Informa Markets, discusses the importance of Pharmapack. […]
FDA Accepts for Priority Review ADX-2191 New Drug Application for the Treatment of Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics has announced that the US Food and Drug Administration (FDA) accepted for Priority […]
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug Conjugate Targeting HER2 for the Treatment of Advanced Solid Tumors
Bio-Thera Solutions, a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase […]
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel […]
First CureDuchenne Clinic Opens in Greater Dallas Area to Provide Specialized Care for Underserved Duchenne Muscular Dystrophy Patients
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, […]
Sooma Medical Receives FDA Breakthrough Device Designation for Its Innovative At-Home Depression Treatment Device
Sooma Medical, a medical device company based in Finland, has been granted Breakthrough Device designation […]
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
Aadi Bioscience Announces Leadership Transition
Aadi Bioscience, a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more